TREZZI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 2.656
AS - Asia 1.531
EU - Europa 1.438
SA - Sud America 375
AF - Africa 38
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.042
Nazione #
US - Stati Uniti d'America 2.585
SG - Singapore 602
CN - Cina 411
IT - Italia 320
BR - Brasile 305
RU - Federazione Russa 265
DE - Germania 254
HK - Hong Kong 237
IE - Irlanda 197
SE - Svezia 127
VN - Vietnam 92
GB - Regno Unito 50
CA - Canada 45
FI - Finlandia 44
AT - Austria 39
IN - India 27
FR - Francia 26
KR - Corea 26
UA - Ucraina 26
TR - Turchia 25
AR - Argentina 24
ID - Indonesia 21
NL - Olanda 21
ZA - Sudafrica 21
BD - Bangladesh 18
EC - Ecuador 18
JP - Giappone 18
PL - Polonia 18
MX - Messico 17
ES - Italia 15
DK - Danimarca 11
PK - Pakistan 11
EG - Egitto 9
CL - Cile 8
IQ - Iraq 7
IL - Israele 6
UZ - Uzbekistan 6
LT - Lituania 5
SA - Arabia Saudita 5
VE - Venezuela 5
AL - Albania 4
CO - Colombia 4
CZ - Repubblica Ceca 4
IR - Iran 4
JO - Giordania 4
PH - Filippine 4
PY - Paraguay 4
AU - Australia 3
BE - Belgio 3
PE - Perù 3
UY - Uruguay 3
AZ - Azerbaigian 2
HN - Honduras 2
MA - Marocco 2
PA - Panama 2
RO - Romania 2
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
PT - Portogallo 1
SV - El Salvador 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.042
Città #
Ann Arbor 509
Singapore 417
Ashburn 253
Hong Kong 237
Chandler 196
Dublin 192
Frankfurt am Main 179
Woodbridge 167
Fairfield 129
Wilmington 90
Beijing 88
New York 88
Dallas 84
Milan 68
Hefei 58
Los Angeles 58
Houston 52
Seattle 50
Princeton 48
Shanghai 48
Cambridge 41
Santa Clara 41
Jacksonville 40
Lissone 34
Moscow 33
Munich 33
São Paulo 31
Dearborn 30
Ho Chi Minh City 30
Vienna 28
Seoul 26
Altamura 23
Hanoi 22
Lawrence 22
Buffalo 21
Chicago 20
Jakarta 17
Nanjing 17
Turku 17
Brooklyn 15
Warsaw 15
The Dalles 14
Tokyo 14
London 12
Helsinki 11
Lachine 11
Montreal 11
Nuremberg 11
Ottawa 11
Columbus 10
Johannesburg 10
Rio de Janeiro 10
Rome 10
San Diego 10
Andover 9
Boardman 9
Caronno Pertusella 9
Toronto 9
Brasília 8
Hangzhou 8
Xi'an 8
Belo Horizonte 7
Campinas 7
Changsha 7
Guangzhou 7
Mexico City 7
Pavia 7
Phoenix 7
San Francisco 7
Shenyang 7
Alexandria 6
Cape Town 6
Charlotte 6
Curitiba 6
Jinan 6
Melzo 6
Roubaix 6
Stockholm 6
Tashkent 6
Boston 5
Chennai 5
Council Bluffs 5
Denver 5
Detroit 5
Kent 5
Lahore 5
Lappeenranta 5
Orem 5
Pune 5
Quito 5
Salt Lake City 5
Santo André 5
Tampa 5
Tel Aviv 5
Ankara 4
Bellaria-Igea Marina 4
Coventry 4
Florence 4
Hebei 4
Istanbul 4
Totale 3.988
Nome #
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 292
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 287
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 256
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 245
Neutrophil Extracellular Traps in the Autoimmunity Context 225
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 219
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 213
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 212
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 212
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 211
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 209
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 202
Novel Therapies in Takayasu Arteritis 193
Immunology of membranous nephropathy: From animal models to humans 179
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 178
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 177
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 174
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 171
Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis 164
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 161
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 160
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 153
Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis 152
Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis 150
ANCA-associated vasculitides (AAV) from the gender point of view 148
Evidence for charge-based mimicry in anti dsDNA antibody generation 144
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 143
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 143
Anti-M-Type Phospholipase A2 Receptor (PLA2R) Antibodies: Diagnostic Performance and Clinical Significance in Idiopathic Membranous Nephropathy (IMN) 142
Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Lupus Nephritis 131
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 129
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 128
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 107
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 102
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 85
Totale 6.197
Categoria #
all - tutte 22.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.030


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021452 0 0 0 0 40 65 76 41 52 75 44 59
2021/2022387 47 67 48 33 11 22 10 22 15 20 36 56
2022/2023738 69 236 101 60 45 105 10 40 43 7 14 8
2023/2024567 17 11 33 22 55 183 103 16 36 17 9 65
2024/20251.617 59 120 127 73 113 59 141 50 184 300 169 222
2025/20261.574 442 208 305 406 213 0 0 0 0 0 0 0
Totale 6.197